365 related articles for article (PubMed ID: 15753538)
21. Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats.
Bolognesi M; Zampieri F; Di Pascoli M; Verardo A; Turato C; Calabrese F; Lunardi F; Pontisso P; Angeli P; Merkel C; Gatta A; Sacerdoti D
Liver Int; 2011 Jul; 31(6):881-90. PubMed ID: 21645220
[TBL] [Abstract][Full Text] [Related]
22. Endocannabinoids acting at vascular CB1 receptors mediate the vasodilated state in advanced liver cirrhosis.
Bátkai S; Járai Z; Wagner JA; Goparaju SK; Varga K; Liu J; Wang L; Mirshahi F; Khanolkar AD; Makriyannis A; Urbaschek R; Garcia N; Sanyal AJ; Kunos G
Nat Med; 2001 Jul; 7(7):827-32. PubMed ID: 11433348
[TBL] [Abstract][Full Text] [Related]
23. Anandamide as an intracellular messenger regulating ion channel activity.
van der Stelt M; Di Marzo V
Prostaglandins Other Lipid Mediat; 2005 Sep; 77(1-4):111-22. PubMed ID: 16099396
[TBL] [Abstract][Full Text] [Related]
24. Anandamide-induced relaxation of sheep coronary arteries: the role of the vascular endothelium, arachidonic acid metabolites and potassium channels.
Grainger J; Boachie-Ansah G
Br J Pharmacol; 2001 Nov; 134(5):1003-12. PubMed ID: 11682448
[TBL] [Abstract][Full Text] [Related]
25. The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in rats.
Kopczyńska B
Life Sci; 2007 Apr; 80(19):1738-45. PubMed ID: 17379256
[TBL] [Abstract][Full Text] [Related]
26. Role of endocannabinoids in the pathogenesis of cirrhotic cardiomyopathy in bile duct-ligated rats.
Gaskari SA; Liu H; Moezi L; Li Y; Baik SK; Lee SS
Br J Pharmacol; 2005 Oct; 146(3):315-23. PubMed ID: 16025138
[TBL] [Abstract][Full Text] [Related]
27. Sperm Release From the Oviductal Epithelium Depends on Ca(2+) Influx Upon Activation of CB1 and TRPV1 by Anandamide.
Gervasi MG; Osycka-Salut C; Sanchez T; Alonso CA; Llados C; Castellano L; Franchi AM; Villalón M; Perez-Martinez S
J Cell Biochem; 2016 Feb; 117(2):320-33. PubMed ID: 26129689
[TBL] [Abstract][Full Text] [Related]
28. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats.
Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B
Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765
[TBL] [Abstract][Full Text] [Related]
29. Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide.
Moezi L; Rezayat M; Samini M; Shafaroodi H; Mehr SE; Ebrahimkhani MR; Dehpour AR
Eur J Pharmacol; 2004 Feb; 486(1):53-9. PubMed ID: 14751408
[TBL] [Abstract][Full Text] [Related]
30. A role for N-arachidonylethanolamine (anandamide) as the mediator of sensory nerve-dependent Ca2+-induced relaxation.
Ishioka N; Bukoski RD
J Pharmacol Exp Ther; 1999 Apr; 289(1):245-50. PubMed ID: 10087011
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory CB1 and activating/desensitizing TRPV1-mediated cannabinoid actions on CGRP release in rodent skin.
Engel MA; Izydorczyk I; Mueller-Tribbensee SM; Becker C; Neurath MF; Reeh PW
Neuropeptides; 2011 Jun; 45(3):229-37. PubMed ID: 21514666
[TBL] [Abstract][Full Text] [Related]
32. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
[TBL] [Abstract][Full Text] [Related]
33. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide.
Zygmunt PM; Petersson J; Andersson DA; Chuang H; Sørgård M; Di Marzo V; Julius D; Högestätt ED
Nature; 1999 Jul; 400(6743):452-7. PubMed ID: 10440374
[TBL] [Abstract][Full Text] [Related]
34. Anandamide induces endothelium-dependent vasoconstriction and CGRPergic nerve-mediated vasodilatation in the rat mesenteric vascular bed.
Tamaki C; Nawa H; Takatori S; Oda S; Sendo T; Zamami Y; Kawasaki H
J Pharmacol Sci; 2012; 118(4):496-505. PubMed ID: 22510966
[TBL] [Abstract][Full Text] [Related]
35. Effects of anandamide and noxious heat on intracellular calcium concentration in nociceptive drg neurons of rats.
Fischbach T; Greffrath W; Nawrath H; Treede RD
J Neurophysiol; 2007 Aug; 98(2):929-38. PubMed ID: 17581853
[TBL] [Abstract][Full Text] [Related]
36. 'Entourage' effects of N-palmitoylethanolamide and N-oleoylethanolamide on vasorelaxation to anandamide occur through TRPV1 receptors.
Ho WS; Barrett DA; Randall MD
Br J Pharmacol; 2008 Nov; 155(6):837-46. PubMed ID: 18695637
[TBL] [Abstract][Full Text] [Related]
37. Anandamide regulates neuropeptide release from capsaicin-sensitive primary sensory neurons by activating both the cannabinoid 1 receptor and the vanilloid receptor 1 in vitro.
Ahluwalia J; Urban L; Bevan S; Nagy I
Eur J Neurosci; 2003 Jun; 17(12):2611-8. PubMed ID: 12823468
[TBL] [Abstract][Full Text] [Related]
38. Effects of chronic nitric oxide synthase inhibition on the cardiovascular responses to cannabinoids in vivo and in vitro.
Wheal AJ; Bennett T; Randall MD; Gardiner SM
Br J Pharmacol; 2007 Mar; 150(5):662-71. PubMed ID: 17245361
[TBL] [Abstract][Full Text] [Related]
39. Central and peripheral components of the pressor effect of anandamide in urethane-anaesthetized rats.
Kwolek G; Zakrzeska A; Schlicker E; Göthert M; Godlewski G; Malinowska B
Br J Pharmacol; 2005 Jul; 145(5):567-75. PubMed ID: 15834445
[TBL] [Abstract][Full Text] [Related]
40. Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret.
Sharkey KA; Cristino L; Oland LD; Van Sickle MD; Starowicz K; Pittman QJ; Guglielmotti V; Davison JS; Di Marzo V
Eur J Neurosci; 2007 May; 25(9):2773-82. PubMed ID: 17459108
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]